All data are based on the daily closing price as of October 1, 2026
l
Lotus Pharmaceutical
1795.TW
5.54 USD
-0.08
-1.42%
Overview
Last close
5.54 usd
Market cap
1.47B usd
52 week high
11.50 usd
52 week low
5.34 usd
Target price
9.15 usd
Valuation
P/E
12.456
Forward P/E
N/A
Price/Sales
1.6531
Price/Book Value
1.9432
Enterprise Value
2.84B usd
EV/Revenue
3.1843
EV/EBITDA
9.0713
Key financials
Revenue TTM
892.13M usd
Gross Profit TTM
479.55M usd
EBITDA TTM
288.18M usd
Earnings per Share
0.45 usd
Dividend
0.08 usd
Total assets
3.42B usd
Net debt
1.64B usd
About
Lotus Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally. Its product portfolio focuses on generics in the fields of oncology, central nervous system, cardiovascular diseases, woman health, and anti-obesity. The company also engages in retail of clinical machines; biotech technological consulting services; sale of pharmaceuticals and medicinal chemical products; marketing activities; market planning and business information services; and consultancy services on health management, health technology, and trading information services. In addition, it offers management consultancy services; pharmaceutical regulatory affairs project management, and data collection and agency services; healthcare consultancy services and operates as a contract research organization. Lotus Pharmaceutical Co., Ltd. was incorporated in 1966 and is headquartered in Taipei City, Taiwan.